MUMBAI, (REUTERS) – Adar Poonawalla, CEO of vaccine maker Serum Institute of India, will buy a 50% stake in filmmaker Karan Johar’s Dharma Productions for 10 billion rupees ($119 million), the ...

What are you driving and why? For my daily drives, I use the Rolls-Royce Phantom, Bentley Flying Spur, Bentley Bentayga, Mercedes-Maybach S 680 or the Land Rover Defender. I also love driving my ...

Adar Poonawalla-led Serene Productions has announced that it has entered into a binding agreement to invest ₹1,000 crore into Karan Johar’s Dharma Productions and Dharmatic Entertainment.

Bollywood filmmaker Karan Johar recently sparked curiosity among fans with a cryptic social media post following his deal with businessman Adar Poonawalla. On Sunday, Karan Johar shared an ...

Also Read: Adar Poonawalla’s Rising Sun Holdings buys 1.75-lakh square feet office space in Pune for ₹395 crore The institute also produces 1.5 billion doses of vaccines for polio, the flu and ...

Days after buying Karan Johar's firm, Adar Poonawalla gets ready to sell 40% stake in one of his companies for Rs.... Billionaire Adar Poonawalla-led Serum Institute is all set for a major deal.

Karan Johar’s Dharma Productions has been making headlines recently. News broke that Adar Poonawalla, CEO of Serum Institute of India, through his Serene Productions, acquired a 50% stake in ...

Poonawalla Fincorp Q2 Results Live : Poonawalla Fincorp declared its Q2 results on October 25, 2024, revealing a topline growth of 33.88%. However, the company reported a significant loss of ...

NBFC Poonawalla Fincorp Ltd on October 25 announced loss of Rs 471 crore for the quarter ended September 30, 2024. It reported net profit of Rs 1,259 crore in the year-ago period. The company's ...

Shares of Poonawalla Fincorp, the Cyrus Poonawalla Group-promoted non-banking financial company (NBFC), crashed on Friday after the firm posted a net loss in the September quarter of the financial ...

Shares of Poonawalla Fincorp on Friday took a sharp beating after the shadow lender declared its second quarter (Q2 FY25) results. The stock cracked 20 per cent to hit a 52-week low of Rs 286.65.

Billionaire Adar Poonawalla-led Serum Institute of India has held discussions with global private equity firm TPG to sell 40% stake held by the top vaccine maker in SCHOTT Poonawalla, four people ...